Evidence map›Paper›PMID 24515445›Full record

ReviewJAMA pediatrics2014

Genetic epidemiology and nonsyndromic structural birth defects: from candidate genes to epigenetics.

Charlotte A Hobbs, Shimul Chowdhury, Mario A Cleves, Stephen Erickson, Stewart L MacLeod, Gary M Shaw, Sanjay Shete, John S Witte, Benjamin Tycko

Abstract readReview
In one paragraph

Review in JAMA pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Deciphering congenital anomalies for the next generation.Cold Spring Harbor molecular case studies · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Charlotte A HobbsDepartment of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock.
Shimul ChowdhuryDepartment of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock.
Mario A ClevesDepartment of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock.
Stephen EricksonDepartment of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock.
Stewart L MacLeodDepartment of Pediatrics, University of Arkansas for Medical Sciences, College of Medicine, Little Rock.
Gary M ShawDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California.
Sanjay SheteDepartment of Epidemiology, University of Texas M. D. Anderson Cancer Center, Houston.
John S WitteDepartment of Epidemiology and Biostatistics, University of California, San Francisco.
Benjamin TyckoDepartment of Pathology and Cell Biology, Institute for Cancer Genetics, Columbia University Medical Center, New York, New York.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Vulnerability to Alzheimers Disease in Down SyndromeP01HD035897 · NICHD · NEW YORK STATE OFFICE OF MENTAL HEALTH · PI KRINSKY-MCHALE, SHARON J · 1998 to 2014
$19.2M
Genomic/Epigenomic Factors and Non-Syndromic Congenital Heart Defect Risk R01HD039054 · NICHD · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI HOBBS, CHARLOTTE A · 2000 to 2016
$13.6M
Centers for Birth Defects Research and Prevention (CBDRPs)U01DD000491 · DD · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI HOBBS, CHARLOTTE A · 2009 to 2013
$4.3M
NCBDD CDC HHS 5U01 DD000491NCBDD CDC HHS U01 DD000491NCI NIH HHS P30 CA016672NICHD NIH HHS P01 HD035897NICHD NIH HHS R01 HD039054
6 · The paper itself

Abstract

Birth defects are a leading cause of infant morbidity and mortality worldwide. The vast majority of birth defects are nonsyndromic, and although their etiologies remain mostly unknown, evidence supports the hypothesis that they result from the complex interaction of genetic, epigenetic, environmental, and lifestyle factors. Since our last review published in 2002 describing the basic tools of genetic epidemiology used to study nonsyndromic structural birth defects, many new approaches have become available and have been used with varying success. Through rapid advances in genomic technologies, investigators are now able to investigate large portions of the genome at a fraction of previous costs. With next-generation sequencing, research has progressed from assessing a small percentage of single-nucleotide polymorphisms to assessing the entire human protein-coding repertoire (exome)-an approach that is starting to uncover rare but informative mutations associated with nonsyndromic birth defects. Herein, we report on the current state of the genetic epidemiology of birth defects and comment on future challenges and opportunities. We consider issues of study design, and we discuss common variant approaches, including candidate gene studies and genome-wide association studies. We also discuss the complexities embedded in exploring interactions between genes and the environment. We complete our review by describing new and promising next-generation sequencing technologies and examining how the study of epigenetic mechanisms could become the key to unraveling the complex etiologies of nonsyndromic structural birth defects.

Indexed as

Epigenesis, GeneticGenetic Predisposition to DiseaseMolecular EpidemiologyCongenital AbnormalitiesGenome-Wide Association StudyHumans

Identifiers

PMID24515445
PMCPMC3981910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.